Key Findings
The Europe pharmaceutical supply chain management market is anticipated to grow with a CAGR of 8.87% during the forecasted period of 2023-2032. The regional market’s growth is set to be propagated by the implementation of the GS1 standard in Europe, in addition to the high adoption rate of advanced technology.

Market Insights
The Europe pharmaceutical supply chain management market study entails the examination of the United Kingdom, Spain, Nordic Countries, Germany, France, Italy, and Rest of Europe. In Italy, the pharmaceutical industry employs over 66,500 staff in 170 sites and contributes around 2% to the nation’s gross domestic product (GDP), particularly from exports. Moreover, biotechnology and biologics are two core areas of Italy’s pharma expertise; these entail pharmaceuticals made from components of living creatures, like proteins generated by the body.
On the other hand, Italy also plays a key role in terms of investing in digital medical innovation, personalized medicine, and precision medicine. Accordingly, a rising number of healthcare providers are focused on digitizing their supply chains. For example, in 2022, UPS announced the acquisition of Bomi Group, an Italy-based healthcare logistics firm, in order to boost its potential to deliver cold storage medicines. The nation is a leading exporter of pharma products, as well, with 80% of domestic drugs being exported to other countries. Therefore, such factors are expected to drive the Europe pharmaceutical supply chain management market growth during the forecasting period.

Competitive Insights
Some of the major enterprises operating in the market are Arvato Supply Chain Solutions, SAP SE, etc.
Our report offerings include:

  • Explore key findings of the overall market
  • Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)
  • Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions
  • Market Segmentation caters to a thorough assessment of key segments with their market estimations
  • Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share
  • Key analytics: Porter’s Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.
  • The competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc.
  • Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments